全文获取类型
收费全文 | 419篇 |
免费 | 21篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 35篇 |
基础医学 | 27篇 |
口腔科学 | 6篇 |
临床医学 | 41篇 |
内科学 | 51篇 |
皮肤病学 | 4篇 |
神经病学 | 27篇 |
特种医学 | 133篇 |
外科学 | 73篇 |
综合类 | 6篇 |
预防医学 | 10篇 |
药学 | 19篇 |
1篇 | |
肿瘤学 | 16篇 |
出版年
2023年 | 1篇 |
2021年 | 5篇 |
2020年 | 2篇 |
2019年 | 1篇 |
2018年 | 5篇 |
2017年 | 3篇 |
2016年 | 2篇 |
2015年 | 4篇 |
2014年 | 8篇 |
2013年 | 16篇 |
2012年 | 10篇 |
2011年 | 8篇 |
2010年 | 8篇 |
2009年 | 11篇 |
2008年 | 7篇 |
2007年 | 11篇 |
2006年 | 11篇 |
2005年 | 2篇 |
2004年 | 5篇 |
2003年 | 3篇 |
2002年 | 7篇 |
2001年 | 10篇 |
2000年 | 9篇 |
1999年 | 11篇 |
1998年 | 20篇 |
1997年 | 15篇 |
1996年 | 26篇 |
1995年 | 16篇 |
1994年 | 21篇 |
1993年 | 16篇 |
1992年 | 4篇 |
1991年 | 9篇 |
1990年 | 7篇 |
1989年 | 20篇 |
1988年 | 17篇 |
1987年 | 23篇 |
1986年 | 12篇 |
1985年 | 12篇 |
1984年 | 10篇 |
1983年 | 12篇 |
1982年 | 10篇 |
1981年 | 9篇 |
1980年 | 8篇 |
1979年 | 5篇 |
1978年 | 1篇 |
1977年 | 6篇 |
1976年 | 9篇 |
1975年 | 2篇 |
排序方式: 共有450条查询结果,搜索用时 250 毫秒
1.
David B. Lumenta MD Eva Siepmann MD Lars‐Peter Kamolz MD PhD 《Wound repair and regeneration》2014,22(4):483-491
No universally accepted standard for evaluation, prevention, and treatment of scars, hypertrophic scars, and keloids exists. Following development of a questionnaire, we performed a closed Web‐based survey among burn centers. Server‐based data collection was performed over 4 weeks and closed thereafter. The poll revealed emerging new treatment schemes, but the majority of participants adhered to evaluation (Patient and Observer Scar Assessment Scale, Matching Assessment of Scars and Photographs, Vancouver Scar Scale, two‐dimensional photography) and prevention (silicone gel sheets and compression garments) strategies that were in line with the currently available recommendations from the literature. We noted a low penetration for the use of objective evaluation tools in our poll and detected differences in surgical approaches to keloids. Based on the results of our survey and the power of currently available clinical recommendations, we expect future guidelines to gain more evidence‐based power, especially when more high‐quality clinical trials with objective evaluation support, clearly defined disease entities, and therapeutic outcome factors have become available. 相似文献
2.
Paul Wurzer MD MMS Raimund Winter MD Sebastian O. Stemmer MD Josipa Ivancic MD Patricia B. Lebo MD Gabriel Hundeshagen MD MMS Janos Cambiaso‐Daniel MD Franz Quehenberger PhD Lars‐Peter Kamolz MD PhD MSc David B. Lumenta 《Wound repair and regeneration》2018,26(1):64-68
Patients suffering from pressure ulcers remain to be a challenging task for nursing staff and doctors in the daily clinical management, putting—notably in the case of recurrences—additional strain on the constantly reduced resources in public healthcare. We aimed to assess the risk factors for the recurrence of pressure ulcers at our institution, a tertiary referral center. In this retrospective analysis of patients admitted to our division we identified risk factors for pressure ulcer recurrence. The hospital patient database search included all patients with a diagnosis of pressure ulcers of the torso and lower extremity. One hundred sixty‐three patients were diagnosed with pressure ulcers and 55 patients with 63 pressure ulcers met our inclusion criteria. The 17 recurrences (27%) had an average follow‐up of 728 days. Most presented with lesions of the ischial tuberosity (n=24). Recurrence was statistically associated with defect size (p = 0.013, Cox regression analysis), and serum albumin levels (p = 0.045, Spearman correlation), but no association was found for body mass index, bacterial profile, comorbidities, localization, previous surgery, or time‐to‐admission for reconstruction (all p > 0.05). Supported by the recent literature we identified factors like defect size to be associated with pressure ulcer recurrence, but not with time‐to admission for reconstruction or number of previous debridements. Whether laboratory values like serum albumin levels were the cause, the result or associated with pressure ulcer recurrence warrants further investigation. 相似文献
3.
Human red cell (RBC) autoantibodies may be the products of a single lymphocyte clone or of a restricted number of clones. For insight into the clonal distribution of human RBC autoantibodies, serum fractions from 28 individuals with various forms of autoimmune hemolytic anemia (AHA) and two nonanemic individuals with positive direct antiglobulin tests were separated by isoelectric focusing (IEF), and RBC binding in each fraction was quantitated with a solid-phase radioimmunoassay. IEF fractions of serum from normal volunteers and patients with nonimmune hemolytic anemia served as controls. These studies indicate that RBC antibodies are found in a restricted number of IEF fractions in sera from some patients with immune hemolytic anemia. IEF fractions containing RBC-binding activity vary among patients with idiopathic AHA, and distinct patterns of binding activity are found in serum from some patients with AHA associated with alphamethyldopa and procainamide or with B-cell immunoproliferative diseases. These findings suggest that the mechanism leading to autoantibody production may differ among patients with the various forms of immune hemolytic anemia. 相似文献
4.
5.
6.
7.
Fourteen patients (20–48 years) suffering from severe head injury were followed for changes in amino acid and protein metabolism during the first 8 days after trauma. All patients received a standardized intravenous nutrition containing 15.7 g of nitrogen per day and additional carbohydrates. Electrolytes, free water, and blood constitutuents were given as needed. Additional treatment included surgical decompression of space-occupying hematomas, high dose dexamethasone therapy, and controlled hyperventilation for at least 5 days. Gross changes of protein metabolism were observed particularly on the days 5 and 6. The duration and chronological sequence of these changes are different from those usually found in patients with multiple injuries. 相似文献
8.
ZALIN AM; JONES S; FITCH NJS; RAMSDEN DB 《QJM : monthly journal of the Association of Physicians》1991,81(2):945-956
Classification of familial amyloidosis by the chemical natureof the fibrillar protein has become possible. Most such amyloidogenicproteins so far recognized are variant transthyretins, but twokindreds with the same apolipoprotein AI modification have beenreported. We describe the clinical features of another suchfamily in whom petechial skin rash appeared to be a marker forthe disease, which was non-neuropathic and of the Ostertag-type.Immunohistochemistry showed the protein to be apolipoproteinAI, but allele-specific DNA amplification indicated that itwas not the Arg26 variant previously identified. 相似文献
9.
Discrepancies in reverse ABO typing due to prozone 总被引:5,自引:0,他引:5
Three group O sera manifesting prozone in reverse ABO tests are reported. All were implicated in erroneous blood typing results. One sample failed to react with A1 red cells (RBCs) in immediate-spin (IS) tests, had anti-A and -B titers of 8192 and 2048, respectively, by indirect antiglobulin technique (IAT), and was from a diabetic patient; the parenteral administration of A substance present in porcine insulin is a possible cause of hyperimmunity in this case. The second sample was from the recipient of a single unit of group B fresh-frozen plasma; the serum anti-A and -B titers were 10,240 by IAT, but only weak reactions with A1 and B RBCs were noted in routine IS reverse typing tests; the hyperimmunity in the patient concerned was likely due to crossreacting anti-A, B stimulated by B-active glycoproteins and/or glycolipids in the transfused plasma. The third serum also had anti-A and anti-B IAT titers of 10,240 but did not react with A1 and B RBCs by IS; the hyperimmunity in this case may be related to sepsis from intestinal flora carrying A- and/or B-like antigens. These antibodies lysed A1 and/or B RBCs in tests incubated at room temperature (RT) and strongly agglutinated those RBCs by IS when diluted 10-fold with saline. The absence of the prozone phenomenon in tests with RBCs suspended in diluents containing EDTA is consistent with the previously published mechanism for anti-A prozone: namely, the steric hindrance of agglutination by the C1 component of human complement.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
10.
H. F. Selig P. Nagele W. G. Voelckel H. Trimmel M. Hüpfl D. B. Lumenta L. P. Kamolz 《European journal of trauma and emergency surgery》2012,38(6):651-657